| Horizon Prosthetics, Llc | |
| 14 Inverness Dr E, Ste G128, Englewood, Colorado 80112 | |
| (303) 660-1238 |
| Name | Horizon Prosthetics, Llc |
|---|---|
| Organization Name | Horizon Prosthetics, Llc |
| Location | 14 Inverness Dr E, Ste G128, Englewood, Colorado 80112 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (303) 660-1238 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Symptoms consistent with focal seizures are often reported by patients who have idiopathic generalised epilepsies and are associated with a short duration of freedom from seizures, say researchers.
Sebelius is on the defensive more than ever now that the White House has delayed a major provision of the law that requires larger employers to offer health insurance to full-time employees. Republicans say she has given a far too rosy picture of progress in carrying out the law. And they are demanding that she explain why people should be required to carry insurance next year if employers are not required to offer it. In her zeal to make the health care law work, Ms. Sebelius has tested the limits of her authority. After Congress refused to provide as much as she wanted for a nationwide campaign publicizing the new insurance options, she shuffled money between government accounts and sought cash from outside groups (Pear, 7/8).
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.
In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
› Verified 2 days ago
| NPI Number | 1316236136 |
| Organization Name | FRONTLINE MEDICAL INNOVATIONS LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4284 Trail Boss Dr, Suite 110, Castle Rock, CO 80104 |
| Phone Number | 303-660-1238 |
News Archive
Symptoms consistent with focal seizures are often reported by patients who have idiopathic generalised epilepsies and are associated with a short duration of freedom from seizures, say researchers.
Sebelius is on the defensive more than ever now that the White House has delayed a major provision of the law that requires larger employers to offer health insurance to full-time employees. Republicans say she has given a far too rosy picture of progress in carrying out the law. And they are demanding that she explain why people should be required to carry insurance next year if employers are not required to offer it. In her zeal to make the health care law work, Ms. Sebelius has tested the limits of her authority. After Congress refused to provide as much as she wanted for a nationwide campaign publicizing the new insurance options, she shuffled money between government accounts and sought cash from outside groups (Pear, 7/8).
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.
In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
› Verified 2 days ago
| NPI Number | 1801289384 |
| Organization Name | HORIZON PROSTHETICS, LLC |
| Doing Business As | FRONTLINE MEDICAL |
| Type | Prosthetic/Orthotic Supplier |
| Address | 9360 Station St Ste 325, Lone Tree, CO 80124 |
| Phone Number | 303-660-1238 |
News Archive
Symptoms consistent with focal seizures are often reported by patients who have idiopathic generalised epilepsies and are associated with a short duration of freedom from seizures, say researchers.
Sebelius is on the defensive more than ever now that the White House has delayed a major provision of the law that requires larger employers to offer health insurance to full-time employees. Republicans say she has given a far too rosy picture of progress in carrying out the law. And they are demanding that she explain why people should be required to carry insurance next year if employers are not required to offer it. In her zeal to make the health care law work, Ms. Sebelius has tested the limits of her authority. After Congress refused to provide as much as she wanted for a nationwide campaign publicizing the new insurance options, she shuffled money between government accounts and sought cash from outside groups (Pear, 7/8).
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.
In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
› Verified 2 days ago
News Archive
Symptoms consistent with focal seizures are often reported by patients who have idiopathic generalised epilepsies and are associated with a short duration of freedom from seizures, say researchers.
Sebelius is on the defensive more than ever now that the White House has delayed a major provision of the law that requires larger employers to offer health insurance to full-time employees. Republicans say she has given a far too rosy picture of progress in carrying out the law. And they are demanding that she explain why people should be required to carry insurance next year if employers are not required to offer it. In her zeal to make the health care law work, Ms. Sebelius has tested the limits of her authority. After Congress refused to provide as much as she wanted for a nationwide campaign publicizing the new insurance options, she shuffled money between government accounts and sought cash from outside groups (Pear, 7/8).
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.
In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).
› Verified 2 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 361 Inverness Dr S, Englewood, Colorado 80112 Phone: (303) 799-6550 | |
Cvs Pharmacy #16033 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6767 S Clinton St, Englewood, Colorado 80112 Phone: (303) 566-0005 | |
Denver Optic Co. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14 Inverness E Dr D146, Englewood, Colorado 80112 Phone: (303) 649-9494 | |
King Soopers Pharmacy #109 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5050 S Federal Blvd, Englewood, Colorado 80110 Phone: (303) 794-6397 | |
King Soopers Pharmacy #111 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3475 S University Blvd, Englewood, Colorado 80113 Phone: (303) 806-2770 |